Effects of Non-Steroidal Mineralocorticoid Antagonist (Finerenone) in Western Diet-Induced Kidney Disease

被引：0
|
作者：
Myakala, Komuraiah [1 ]
Ribeiro, Patricia de Carvalho [1 ]
Wang, Xiaoxin [1 ]
Korolowicz, Kyle E. [1 ]
Rodriguez, Olga C. [1 ]
Albanese, Chris [1 ]
Levi, Moshe [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO242
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [1] Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease
    Verma, Ashish
    Patel, Ankit B.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (05): : 261 - 263
  • [2] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Beavers, Craig J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (12) : 1785 - 1790
  • [3] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Craig J. Beavers
    Current Cardiology Reports, 2022, 24 : 1785 - 1790
  • [4] Finerenone - are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1253 - 1256
  • [5] The non-steroidal mineralocorticoid receptor antagonist finerenone improves left ventricular function in preclinical chronic kidney disease
    Stephan, Y.
    Lima-Posada, I.
    Souille, M.
    Bonnard, B.
    Palacios, R.
    Nicol, L.
    Kolkhof, P.
    Jaisser, F.
    Mulder, P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2933 - 2933
  • [6] The Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction In Preclinical Non-diabetic Chronic Kidney Disease
    Posada, Ixchel Lima
    Stephan, Yohan
    Soulie, Matthieu
    Palacios-Ramirez, Roberto
    Bonnard, Benjamin
    Kolkhof, Peter
    Mulder, Paul
    Jaisser, Frederic
    HYPERTENSION, 2023, 80
  • [7] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
    Lavall, D.
    Jacobs, N.
    Mahfoud, F.
    Kolkhof, P.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3326 - 3326
  • [8] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling
    Lavall, Daniel
    Jacobs, Nadine
    Mahfoud, Felix
    Kolkhof, Peter
    Boehm, Michael
    Laufs, Ulrich
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 173 - 183
  • [9] Effects Of Finerenone - A Novel Non-steroidal Mineralocorticoid Receptor Antagonist In A Model Of Pressure Overload-induced Cardiac Hypertrophy
    Grune, Jana
    Benz, Verena
    Brix, Sarah
    Ban, Zsofia
    Salatzki, Janek
    Hoeft, Beata
    Foryst-Ludwig, Anna
    Klopfleisch, Robert
    Kolkhof, Peter
    Kintscher, Ulrich
    HYPERTENSION, 2014, 64
  • [10] Effects of Finerenone - a novel non-steroidal mineralocorticoid receptor antagonist in a model of pressure overload-induced cardiac hypertrophy
    Grune, J.
    Benz, V
    Brix, S.
    Ban, Z.
    Janek, S.
    Foryst-Ludwig, A.
    Klopfleisch, R.
    Kolkhof, P.
    Kintscher, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S35 - S35
12345